Rani Therapeutics Holdings (RANI) Current Assets (2020 - 2026)

Rani Therapeutics Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $47.1 million for Q1 2026.

• On a quarterly basis, Current Assets rose 164.81% year-over-year to $47.1 million in Q1 2026; TTM through Mar 2026 was $47.1 million, a 164.81% increase from a year earlier, with the FY2025 full-year figure at $53.3 million, up 79.27% from the prior year.
• Current Assets slipped to $47.1 million in Q1 2026 per RANI's latest filing, from $53.3 million in the prior quarter.
• Across five years, Current Assets topped out at $109.3 million in Q1 2022 and bottomed at $5.0 million in Q3 2025.
• The 5-year median for Current Assets is $50.8 million (2023), against an average of $56.4 million.
• Across the five-year window, Current Assets tumbled 84.69% in 2025 and soared 164.81% in 2026, its largest moves.
• Year by year, Current Assets stood at $100.9 million in 2022, then slumped by 49.62% to $50.8 million in 2023, then plunged by 41.5% to $29.7 million in 2024, then surged by 79.27% to $53.3 million in 2025, then dropped by 11.68% to $47.1 million in 2026.
• Per Business Quant, the three latest RANI Current Assets figures stand at $47.1 million (Q1 2026), $53.3 million (Q4 2025), and $5.0 million (Q3 2025).